122 related articles for article (PubMed ID: 37357186)
1. [Long-term mortality risk of valvular heart disease adults over 35 years old in Chinese communities].
Gu RQ; Qiu JY; Zheng CY; Wu JM; Nie ZJ; Zhang LF; Chen Z; Wang X; Hu Z; Song YX; Zhang DD; Shan WP; Cao X; Tian YX; Shao L; Tian Y; Pan XB; Wang ZW
Zhonghua Yi Xue Za Zhi; 2023 Jun; 103(24):1818-1823. PubMed ID: 37357186
[No Abstract] [Full Text] [Related]
2. Current status and etiology of valvular heart disease in China: a population-based survey.
Yang Y; Wang Z; Chen Z; Wang X; Zhang L; Li S; Zheng C; Kang Y; Jiang L; Zhu Z; Gao R
BMC Cardiovasc Disord; 2021 Jul; 21(1):339. PubMed ID: 34256700
[TBL] [Abstract][Full Text] [Related]
3. Determinants of Bioprosthetic Aortic Valve Degeneration.
Nitsche C; Kammerlander AA; Knechtelsdorfer K; Kraiger JA; Goliasch G; Dona C; Schachner L; Öztürk B; Binder C; Duca F; Aschauer S; Zimpfer D; Bonderman D; Hengstenberg C; Mascherbauer J
JACC Cardiovasc Imaging; 2020 Feb; 13(2 Pt 1):345-353. PubMed ID: 30878425
[TBL] [Abstract][Full Text] [Related]
4. Stages of Valvular Heart Disease Among Older Adults in the Community: The Atherosclerosis Risk in Communities Study.
Shelbaya K; Claggett B; Dorbala P; Skali H; Solomon SD; Matsushita K; Konety S; Mosley TH; Shah AM
Circulation; 2023 Feb; 147(8):638-649. PubMed ID: 36524478
[TBL] [Abstract][Full Text] [Related]
5. Survival of people with valvular heart disease in a large, English community-based cohort study.
Taylor CJ; Ordóñez-Mena JM; Jones NR; Roalfe AK; Myerson SG; Prendergast BD; Hobbs FR
Heart; 2021 Aug; 107(16):1336-1343. PubMed ID: 34031157
[TBL] [Abstract][Full Text] [Related]
6. Valvular Heart Disease Patients on Edoxaban or Warfarin in the ENGAGE AF-TIMI 48 Trial.
De Caterina R; Renda G; Carnicelli AP; Nordio F; Trevisan M; Mercuri MF; Ruff CT; Antman EM; Braunwald E; Giugliano RP
J Am Coll Cardiol; 2017 Mar; 69(11):1372-1382. PubMed ID: 28302288
[TBL] [Abstract][Full Text] [Related]
7. Characteristics, interventions and outcomes of patients with valvular heart disease hospitalised in China: a cross-sectional study.
Huang X; Dhruva SS; Yuan X; Bai X; Lu Y; Yan X; Liu J; Li W; Hu D; Ji R; Gao M; Miao F; Li J; Ge J; Krumholz HM; Li J
BMJ Open; 2021 Nov; 11(11):e052946. PubMed ID: 34732492
[TBL] [Abstract][Full Text] [Related]
8. Lack of progress in valvular heart disease in the pre-transcatheter aortic valve replacement era: increasing deaths and minimal change in mortality rate over the past three decades.
Coffey S; Cox B; Williams MJ
Am Heart J; 2014 Apr; 167(4):562-567.e2. PubMed ID: 24655706
[TBL] [Abstract][Full Text] [Related]
9. Stroke, thromboembolism and bleeding in patients with atrial fibrillation according to the EHRA valvular heart disease classification.
Bisson A; Bodin A; Clementy N; Bernard A; Babuty D; Lip GYH; Fauchier L
Int J Cardiol; 2018 Jun; 260():93-98. PubMed ID: 29540261
[TBL] [Abstract][Full Text] [Related]
10. Changing causes of heart valve disease mortality in New Zealand from 1988 to 2007.
Coffey S; Cox B; Williams MJ
N Z Med J; 2016 Jan; 129(1428):56-65. PubMed ID: 26914193
[TBL] [Abstract][Full Text] [Related]
11. A prospective survey of patients with valvular heart disease in Europe: The Euro Heart Survey on Valvular Heart Disease.
Iung B; Baron G; Butchart EG; Delahaye F; Gohlke-Bärwolf C; Levang OW; Tornos P; Vanoverschelde JL; Vermeer F; Boersma E; Ravaud P; Vahanian A
Eur Heart J; 2003 Jul; 24(13):1231-43. PubMed ID: 12831818
[TBL] [Abstract][Full Text] [Related]
12. Impact of Valvular Heart Disease on Mortality, Thromboembolic and Cardiac Events in Japanese Patients With Atrial Fibrillation - The Fushimi AF Registry.
Doi K; Ogawa H; Ishigami K; Ikeda S; Aono Y; Hamatani Y; Fujino A; An Y; Ishii M; Iguchi M; Masunaga N; Esato M; Tsuji H; Wada H; Hasegawa K; Abe M; Akao M;
Circ J; 2020 Apr; 84(5):714-722. PubMed ID: 32213725
[TBL] [Abstract][Full Text] [Related]
13. Contemporary Presentation and Management of Valvular Heart Disease: The EURObservational Research Programme Valvular Heart Disease II Survey.
Iung B; Delgado V; Rosenhek R; Price S; Prendergast B; Wendler O; De Bonis M; Tribouilloy C; Evangelista A; Bogachev-Prokophiev A; Apor A; Ince H; Laroche C; Popescu BA; Piérard L; Haude M; Hindricks G; Ruschitzka F; Windecker S; Bax JJ; Maggioni A; Vahanian A;
Circulation; 2019 Oct; 140(14):1156-1169. PubMed ID: 31510787
[TBL] [Abstract][Full Text] [Related]
14. Periodontitis is associated with incidental valvular heart disease: A nationwide population-based cohort study.
Sia SK; Jan MS; Wang YH; Huang YF; Wei JC
J Clin Periodontol; 2021 Aug; 48(8):1085-1092. PubMed ID: 34060116
[TBL] [Abstract][Full Text] [Related]
15. Prognostic Value of N-Terminal Pro-B-Type Natriuretic Peptide in Elderly Patients With Valvular Heart Disease.
Zhang B; Xu H; Zhang H; Liu Q; Ye Y; Hao J; Zhao Q; Qi X; Liu S; Zhang E; Xu Y; Gao R; Pibarot P; Clavel MA; Wu Y;
J Am Coll Cardiol; 2020 Apr; 75(14):1659-1672. PubMed ID: 32273031
[TBL] [Abstract][Full Text] [Related]
16. Comparison of Dabigatran and Warfarin in Patients With Atrial Fibrillation and Valvular Heart Disease: The RE-LY Trial (Randomized Evaluation of Long-Term Anticoagulant Therapy).
Ezekowitz MD; Nagarakanti R; Noack H; Brueckmann M; Litherland C; Jacobs M; Clemens A; Reilly PA; Connolly SJ; Yusuf S; Wallentin L
Circulation; 2016 Aug; 134(8):589-98. PubMed ID: 27496855
[TBL] [Abstract][Full Text] [Related]
17. Five-year epidemiological survey of valvular heart disease: changes in morbidity, etiological spectrum and management in a cardiovascular center of Southern China.
Liu FZ; Xue YM; Liao HT; Zhan XZ; Guo HM; Huang HL; Fang XH; Wei W; Rao F; Deng H; Liu Y; Lin WD; Wu SL
J Thorac Dis; 2014 Dec; 6(12):1724-30. PubMed ID: 25589965
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of valvular heart diseases and associated risk factors in Han, Uygur and Kazak population in Xinjiang, China.
Wang YT; Tao J; Maimaiti A; Adi D; Yang YN; Li XM; Ma X; Liu F; Chen BD; Ma YT
PLoS One; 2017; 12(3):e0174490. PubMed ID: 28355290
[TBL] [Abstract][Full Text] [Related]
19. Associations of long-term exposure to traffic-related air pollution with risk of valvular heart disease based on a cross-sectional study.
Pang Y; Liu S; Yan L; Wang Q; Li L; Chu C; Ning J; Zhang B; Wang X; Ma S; Su D; Zhang R; Niu Y
Ecotoxicol Environ Saf; 2021 Feb; 209():111753. PubMed ID: 33348255
[TBL] [Abstract][Full Text] [Related]
20. Stroke and bleeding risk scores in patients with atrial fibrillation and valvular heart disease: evaluating 'valvular heart disease' in a nationwide cohort study.
Lip GYH; Jensen M; Melgaard L; Skjøth F; Nielsen PB; Larsen TB
Europace; 2019 Jan; 21(1):33-40. PubMed ID: 29986001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
